Premium
Occipital Nerve Stimulation for Medically Refractory Chronic Paroxysmal Hemicrania
Author(s) -
Miller Sarah,
Lagrata Susie,
Watkins Laurence,
Matharu Manjit
Publication year - 2017
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/head.13187
Subject(s) - medicine , refractory (planetary science) , occipital nerve stimulation , anesthesia , cluster headache , surgery , migraine , physics , alternative medicine , pathology , astrobiology
Objective To describe the outcome of a patient with refractory chronic paroxysmal hemicrania (CPH) to occipital nerve stimulation (ONS). Background CPH is a primary headache disorder exquisitely sensitive to indomethacin. In patients unable to tolerate indomethacin, the therapeutic options are limited. ONS is a promising therapy for other refractory headache conditions. We report the first patient with medically refractory CPH treated with ONS. Methods Following implantation of the occipital nerve stimulator in 2006, the patient kept prospective headache diaries. Outcome was assessed by daily attack frequency. Results After a follow‐up of over 10 years, the patient reported a sustained efficacy of more than 50% reduction in attack frequency and was pain‐free at final follow‐up. The patient was able to stop indomethacin completely. The patient had three successful pregnancies during follow‐up. One system revision was undertaken alongside an expected battery replacement to treat unequal paresthesia and pain over the electrodes. Conclusion ONS may offer an effective long‐term treatment for CPH in patients where indomethacin cannot be tolerated.